Juventas Therapeutic raises $13.5 million for clinical trials

Story excerpt provided by Crain’s Cleveland Business.

Written by Timothy Magaw.

Juventas Therapeutics, a Cleveland-based clinical-stage company developing regenerative therapies for treatment of cardiovascular diseases, has secured $13.5 million in financing to support future clinical studies.

Click here to read the complete article.

Originally published May 12, 2015.